Search Results
Results found for "Design Pharmaceuticals"
- Accelerating GPCR Drug Discovery
Systems That Drive Progress: From assay tracking to data workflows, I design simple, scalable tools
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
who has just released an incredible article on our site and a GPCR Paper with his team: Targeted Drug Design November 14th : The Application of GPCR Ligand Kinetics to Candidate Design.
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Group Corporation (“the Company”; TSE: 4565), the world leader in GPCR-focused structure-based drug design
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Our updated course schedule is designed to fit seamlessly into your routine, offering an enriched learning Boston, MA 📅 October 2 -3, 2024 Join top researchers to explore the latest in GPCR-targeted drug design
- Functional molecular switches of mammalian G protein-coupled bitter-taste receptors
We designed an integrative approach to improve comparative modeling of TAS2Rs.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor Design
- From GPCR Data Chaos to Decisive Action
Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
brain vs. peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed
- 📰 GPCR Weekly News, February 19 to 25, 2024
restoration of tension in epithelial cells GPCR Binders, Drugs, and more Advances in structure-based drug design copolymers and SMALPs as a platform for investigating GPCRs Reviews, GPCRs, and more Fragment-Based Design
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
understandings of CB2 signaling, tools that preserve cellular context will be increasingly important for designing Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
We designed and synthetized peptides that interfered with integrin αIIb binding (pCIB and pCIBm) or mimicked
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse Enter Collaboration To Design Using Generative AI Zombie Fungi Hijack Hosts’ Brains GPCR Therapeutics, Inc. has received Orphan Drug Designation
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Our refreshed schedule is designed to fit seamlessly into your calendar and enhance your learning experience (October 2-3, 2024, in Boston and online) gathers top researchers to explore the latest advances in designing
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
The pharmacological profiles and mechanistic insights of our study provide clues for the future design
- Targeting Intracellular Allosteric Sites in GPCRs
The process of designing and evaluating biased ligands for GPCRs is complex but essential for understanding Advances in understanding the structural and mechanistic aspects of biased GPCR signaling are crucial for designing
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
MQ1-K39A represents the first step in the improvement of the MQ1 design from a medicinal perspective.
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed to design
- How Fast Does a Drug Work?
Kenakin’s latest lecture delivers exclusive, real-world insight designed to equip you to move beyond
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
At Celtarys, our GPCR fluorescent ligands are designed with a variety of photophysical properties to
- Why “Displacement” Misleads You: Allosteric Binding Demystified
radioligand binding but suppresses functional response, it’s not broken pharmacology—it’s biology working as designed
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
receptor, which could participate in the recognition of MT1-selective ligands and may be exploited in the design
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Methods: To address this question, we studied mice that express a Gs-coupled designer G protein-coupled
- How Schild Analysis Protects Your Conclusions in GPCR Research
GPCR University content, and an integrated view of publications, events, insights, and opportunities designed
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
At Celtarys, we support this transition by offering optimized fluorescent ligands specifically designed
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
lectures, classified industry news, priority event alerts, job opportunities, and insider commentary—designed
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
beyond natural agonist analogs Awareness of how GPCR allostery and biased signaling are redefining drug design
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
translational research models, further refining his interest in bridging molecular insights with therapeutic design
- 📰 GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of



















